Catalyst Wire Dossier Catalyst Wire Dossier

CYNK-001

· Celularity Incorporated
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CYNK-001, covering 2022-05-25 to 2024-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Natural Killer Cell (CYNK-001) Infusions in Adults with AML [Phase 1]

See pricing